Saffron - Spice.

Crocin is the water-soluble carotenoid glycoside that gives saffron its colour and carries much of its measured activity. Standardising on crocin is how the whole spice is quantified.

Tryptophan supplies the substrate for serotonin synthesis while saffron constituents act on serotonin handling at the synapse. The two enter the same normal signalling pathway at different points, which is the basis for pairing them in mood-support formulas.

5-HTP is the immediate precursor decarboxylated to serotonin, and saffron constituents act on how serotonin is handled once released. Formulators pair a precursor with a synaptic-side ingredient rather than stacking two precursors.

Aromatic amino acid decarboxylase, the enzyme that converts 5-hydroxytryptophan to serotonin, needs pyridoxal-5-phosphate as its cofactor. Adding B6 to a saffron and tryptophan pathway formula covers that cofactor requirement.

Saffron constituents are studied against sleep quality measures in healthy adults, and theanine acts on glutamatergic and GABAergic signalling with a different onset profile. The two are combined in evening formulations for that complementarity. No trial has tested the pair together, so the combination rests on each ingredient's separate record.

In a randomised double-blind trial in healthy adults reporting poor sleep, saffron was assessed against placebo on sleep quality measures. Melatonin acts through MT1 and MT2 receptors on sleep timing rather than on subjective quality. The two address different aspects of the same formulation goal. They have not been tested together.

Magnesium is required by the kinases and decarboxylases that build and turn over monoamine neurotransmitters, and it modulates NMDA receptor gating. Saffron constituents act downstream on monoamine signalling. Adequate magnesium is a background requirement for that signalling rather than an amplifier of saffron specifically.

Crocin and crocetin are carotenoid-derived and have been reviewed as retinal neuroprotectants in preclinical and clinical work. Zeaxanthin is one of the two xanthophylls that make up macular pigment. Both are studied against retinal tissue endpoints from different chemical starting points. The preclinical body is stronger than the clinical one, and this row reflects that.

Saffron's crocetin esters are water-soluble carotenoids that reach retinal tissue after hydrolysis to crocetin, while lutein is a lipophilic xanthophyll deposited in macular pigment. The two occupy different compartments of the same tissue. The combination is formulated on that basis and has not been tested as a pair.

Carotenoids travel in lipoproteins and their tissue delivery tracks with dietary lipid intake. DHA is the dominant fatty acid of photoreceptor outer segment membranes. Taking a carotenoid-bearing extract with a fat source improves the odds of absorption, which is a general carotenoid principle rather than a saffron-specific finding.

Piperine slows UDP-glucuronosyltransferase and some CYP-mediated clearance, which raises systemic exposure to compounds handled by those routes. Crocetin is glucuronidated after absorption, so the mechanism applies in principle. The interaction has not been measured for saffron specifically, and piperine raises exposure to co-administered substances generally, which cuts both ways.

Saffron has randomised human data on sleep quality and mood measures; ashwagandha withanolides are studied against cortisol and stress-response measures. The mechanisms do not overlap, which is the formulation rationale for combining them. No study has tested the two together, so the pairing rests on each record separately.

Rosavins and salidroside are studied against fatigue and mental performance measures, while saffron's crocins and safranal are studied against mood measures. The categories overlap in use and not in chemistry. This is a formulation pairing without combination data.

Curcuminoids and crocetin esters are both intensely coloured, both are rapidly conjugated after absorption, and both are studied against overlapping inflammatory and oxidative markers. Combining them loads shared conjugation capacity, which can raise unconjugated exposure to either. Markers are markers, not outcomes.

In a defined gut consortium, saffron altered microbial amino acid metabolism and the neurotransmitter-related products the community generated. That places saffron upstream of microbial metabolism rather than acting only on host tissue. Whether a co-administered yeast or bacterial strain changes that output is untested, and the finding is in vitro.

Saffron shifted amino acid metabolism and neurotransmitter production in a defined bacterial consortium, which is a plausible route by which a botanical could affect gut-derived signalling molecules. Bifidobacteria are part of the community that carries that metabolism. This is a laboratory model, not a human measurement, and the row is labelled accordingly.

Crocins are oxidation-sensitive polyene glycosides. Ascorbate scavenges aqueous-phase oxidants and helps regenerate oxidised phenolics, which reduces degradation before absorption. The chemistry is general to carotenoids and phenolics. It has not been quantified for saffron in people.

The conjugated double bond system in crocetin is the reactive site that gives saffron its colour and its oxidative fragility. Tocopherols terminate lipid peroxyl chains at that interface. The pairing is stabilisation chemistry used in formulation and does not by itself imply a physiological benefit.

Ginkgo flavone glycosides and terpene lactones are studied against microcirculatory measures, and saffron carotenoids have been reviewed as retinal neuroprotectants in preclinical work. The endpoints overlap; the chemistry does not. No combination study exists and the saffron side is stronger preclinically than clinically.

Bacosides and saffron crocins are studied in overlapping cognitive and mood measurement territory, using different mechanisms. Combining them is a formulation decision rather than a tested one. Each ingredient's evidence stands on its own.

Apigenin binds benzodiazepine sites with low affinity and is the flavone behind chamomile's evening use. Saffron has randomised human data on sleep quality measures in healthy adults reporting poor sleep. The two are combined on that shared use case without any combination data.

Astaxanthin is a lipophilic xanthophyll that partitions into membranes; saffron's crocins are water-soluble crocetin glycosides hydrolysed to crocetin before absorption. That solubility difference means they reach tissue by different routes. Both have preclinical retinal literature and neither pairing has been tested clinically.